Cancer Immunology, Immunotherapy Issues Research Articles in January 2022 Edition
January 07, 2022
January 07, 2022
BASEL, Switzerland, Jan. 7 -- Cancer Immunology, Immunotherapy, a peer-reviewed journal that says it advances in the field of tumor immunology, published research articles on the following topics in its January 2022 edition:
Original Articles:
* Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature
* Impact of preoperative plasma levels of interleukin 6 and interl . . .
Original Articles:
* Lenalidomide enhances the efficacy of anti-BCMA CAR-T treatment in relapsed/refractory multiple myeloma: a case report and revies of the literature
* Impact of preoperative plasma levels of interleukin 6 and interl . . .